Increased prices for health care services are a major driver of overall spending growth, and this has led to higher costs for consumers in commercial plans.
Americans have high out-of-pocket medical costs relative to their income
Health care spending growth is a perpetual policy concern in the United States. High spending threatens the sustainability of public insurance programs and affects premium costs and out-of-pocket cost-sharing for the more than 170 million Americans enrolled in commercial plans.11
Fee-for-service payment models have left many providers financially vulnerable in the wake of social-distancing restrictions and lower demand for care.
Short-term revenue losses among providers will certainly rebound, but the long-term impact of the pandemic on providers’ bottom line is uncertain.12 To the extent that volumes remain lower than once expected or the supply of providers decreases within markets, providers may raise prices.
Prices paid by commercial insurers are higher than Medicare rates for similar services
Researchers and policymakers have been able to track spending for health care services, but only recently have they been able to break down total spending estimates into utilization and price-per-service components. Estimates suggest that about three-quarters of the growth in health care spending between 2014 and 2018 can be attributed to price increases.13
A recent state analysis compared prices paid by commercial employer-sponsored plans for inpatient hospital services to Medicare payment rates for similar services. It found significant variation, with commercial insurers paying between 140 percent of Medicare prices in Hawaii and 274 percent in Oregon.14 Prices can vary for a number of reasons. In Rhode Island, for example, where prices are 158 percent of Medicare, the state drove down prices through insurer rate regulation.15 The presence of market-dominant, not-for-profit insurers with strong price negotiation leverage also can work to mitigate higher prices.
High prices have consequences. When health providers charge private insurers higher prices, insurers pass along those higher costs to employers by increasing premiums. Ultimately, employees bear the burden through higher premium contributions, deductibles, out-of-pocket medical costs, and reduced wages. States where providers charge the highest prices also tended to have the highest average premium costs in terms of both employer and employee contributions.
Prices for hospital inpatient care paid by commercial insurers are higher than Medicare prices in every state
Higher premiums for employer coverage are associated with higher commercial prices for health care services, 2017
U.S. investment in primary care is low and could be further weakened by the pandemic.
The COVID-19 pandemic fueled a 70 percent drop in in-person outpatient visits in March 2020, including a 50 percent drop for primary care providers. This was the result of social distancing restrictions, public fear of the virus, and safety precautions taken by providers.16 Visit volumes have rebounded somewhat, and that will continue. Still, primary care’s vulnerability to steep demand and revenue declines is concerning.
Pre-COVID data on primary care spending can inform our eventual understanding of the outbreak’s impact. Among Medicare beneficiaries in 2017, for example, primary care accounted for just under 6 percent of all medical spending, translating to about $712 per beneficiary per year nationally. State rates ranged from less than 5 percent in Rhode Island and New Hampshire to more than 7 percent in Tennessee. American investment in primary care was already low relative to international benchmarks. Among Medicare beneficiaries, for example, primary care spending amounts to only about half the OECD country average of 12 percent.17 There is significant uncertainty about whether the combined effects of the pandemic and economic collapse will further drive down primary care use. If that scenario materializes, forgone care and subsequent gaps in chronic disease management will contribute to avoidable illness and higher non-COVID mortality.18